📰 Treating Ulcerative News
Treating Ulcerative News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Treating Ulcerative. Real-time updates on events, politics, business and more.
February 13, 2024
PARIS, FRANCE / ACCESSWIRE / February 13, 2024 / Abivax SA (Euronext Paris:ABVX))(NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients...
February 13, 2024
EQS-News: ABIVAX / Key word: Conference Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th...
February 13, 2024
Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative ...
February 13, 2024
EQS-News: ABIVAX / Key word(s): ConferenceAbivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO) 13.02.2024 / 08:30 CET/CESTThe issuer is solely responsible for the content o...
January 22, 2024
EQS-News: ABIVAX / Key word: Miscellaneous Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months 22.01.2024 / 08:30 CET/CEST The...